Evaluation of medication adherence of glaucoma patients during the COVID-19 pandemic

Basit Öğe Kaydı
dc.contributor.authorFirat, P. G.
dc.contributor.authorDikci, S.
dc.contributor.authorCan, A.
dc.contributor.authorTuerkoglub, E. B.
dc.date.accessioned2024-08-04T20:53:11Z
dc.date.available2024-08-04T20:53:11Z
dc.date.issued2023
dc.departmentİnönü Üniversitesien_US
dc.description.abstractPurpose. - To evaluate changes in the medication adherence of glaucoma patients during the COVID-19 pandemic and the factors influencing medication adherence.Materials and methods. - This cross-sectional study included a total of 197 glaucoma patients who were followed for at least six months in the Glaucoma Unit of the Ophthalmology Department of Inonu University, Faculty of Medicine. Patients were given a 28-item questionnaire, including the eight-item Morisky Medication Adherence Questionnaire, to evaluate medication adherence. Demographic and clinical data were recorded. P < 0.05 was considered statistically significant.Results. - Interruption of glaucoma clinic visits during the pandemic was reported by 82 (41.6%) patients. Nonadherence was reported by 56 patients (28.4%) (95% confidence interval: 22.1-34.7). For these patients, the most common reasons for nonadherence were forgetfulness (50%), the inability to receive a prescription for the drug (10.7%) and being busy (10.7%). Factors influencing nonadherence were determined to be younger age, female gender, interruption of glaucoma clinic visits and high-income levels (P < 0.05).Conclusion. - Interruption of glaucoma clinic visits during the COVID-19 pandemic and the resulting inability to have medications prescribed resulted in patient nonadherence with medication use.& COPY; 2022 Published by Elsevier Masson SAS.en_US
dc.identifier.doi10.1016/j.jfo.2022.09.006
dc.identifier.endpage18en_US
dc.identifier.issn0181-5512
dc.identifier.issn1773-0597
dc.identifier.issue1en_US
dc.identifier.pmid36435659en_US
dc.identifier.scopus2-s2.0-85142424002en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage11en_US
dc.identifier.urihttps://doi.org/10.1016/j.jfo.2022.09.006
dc.identifier.urihttps://hdl.handle.net/11616/101011
dc.identifier.volume46en_US
dc.identifier.wosWOS:001029623000001en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherMasson Editeuren_US
dc.relation.ispartofJournal Francais D Ophtalmologieen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectGlaucomaen_US
dc.subjectAdherenceen_US
dc.subjectComplianceen_US
dc.subjectQuestionnaireen_US
dc.subjectMedicationen_US
dc.titleEvaluation of medication adherence of glaucoma patients during the COVID-19 pandemicen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu